Notably, galectin-3 levels are also elevated in BALF and serum of IPF patients [10,34], with inhaled administration of a galectin-3 inhibitor showing promising results in IPF progression [35]. The gene discussed is LGALS3; the disease is idiopathic pulmonary fibrosis.